Increasing Utilization Of Deceased Donor Kidneys: Modeling Outcomes Using Kidneys From Hcv-Infected Donors For Hcv-Uninfected Recipients
Posted Date: Sep 5, 2019
- Investigator: Mark Eckman
- Specialties: Liver Disease, Nephrology
- Type of Study: Observational/Survey
Fewer than 4% of patients with end stage renal disease (ESRD) receive kidney transplants, in large part because many more patients are waiting to receive kidneys than there are kidneys available. There is growing clinical trial evidence that using kidneys from deceased donors with chronic hepatitis C virus can decrease waiting times for otherwise high quality kidneys, thereby improving survival and quality of life. While this strategy may be best for the average ESRD patient awaiting transplantation, there is great variability in waiting list times and individual patient values and preferences for health outcomes. Therefore, it is important to develop models that will help us to better understand which patients might benefit the most, and decision support tools to facilitate shared decision-making discussions between patients and their doctors.
Subjects Will Be Included Who Are Receiving Hemodialysis, Are Between 21 And 80 Years Of Age, And Are Receiving Care From A Faculty Member Of The Division Of Nephrology At The University Of Cincinnati.
End Stage Kidney Disease, Kidney Transplantation, Decision Analysis
For More Information:
Mark H. Eckman, Md, Ms